Evaluation of the tyrosine kinase domain of the Met proto-oncogene in sporadic ovarian carcinomas* (Q73003047)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10491015%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Evaluation of the tyrosine kinase domain of the Met proto-oncogene in sporadic ovarian carcinomas* (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10491015%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

J Tanyi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10491015%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K Tory

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10491015%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J Rigó

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10491015%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

B Nagy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10491015%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Z Papp

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10491015%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10491015%20AND%20SRC:MED&resulttype=core&format=json

Pathology and Oncology Research

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10491015%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10491015%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10491015%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

187-191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10491015%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

cites work

Ovarian cancer biology

1 reference

12 December 2020

Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor

1 reference

12 December 2020

Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy

1 reference

12 December 2020

Tyrosine kinase receptor indistinguishable from the c-met protein

1 reference

12 December 2020

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

1 reference

12 December 2020

The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells

1 reference

12 December 2020

Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros

1 reference

12 December 2020

Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development

1 reference

12 December 2020

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

1 reference

12 December 2020

Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas

1 reference

12 December 2020

Molecular cytogenetics of renal cell tumors

1 reference

12 December 2020

Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and inducti

1 reference

12 December 2020

Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer

1 reference

12 December 2020

Karyotypic characteristics of borderline malignant tumors of the ovary: trisomy 12, trisomy 7, and r(1) as nonrandom features

1 reference

12 December 2020

Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud

1 reference

12 December 2020

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

1 reference

12 December 2020

Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network

1 reference

12 December 2020

Overexpression of the Met/HGF receptor in ovarian cancer.

1 reference

12 December 2020

Overexpression of the met/HGF receptor in renal cell carcinomas

1 reference

12 December 2020

Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas

1 reference

12 December 2020

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

1 reference

12 December 2020

The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors

1 reference

12 December 2020

Trisomy 12 correlates with elevated expression of p21 ras in a human adenosquamous carcinoma of the lung

1 reference

12 December 2020

Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas

1 reference

12 December 2020